课题基金 / 基金详情

Development of gene theropy for glaucoma by neaws of modulation of proteoglycan praduction in aqueous outflow rocite

Development of gene theropy for glaucoma by neaws of modulation of proteoglycan praduction in aqueous outflow rocite
通过调节房水流出液中蛋白多糖的产生来开发青光眼基因疗法
批准号:
08457464
负责人:
TANIHARA Hidenobu
金额:
$4.74万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

TANIHARA Hidenobu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have investigated our hypothesis on mechanism of primary angly open glaucoma, that an interactive relationship between TGF-beta2 in aqueous humor and proteoglycan (PG) expression in trabecular meshwork (TM) cells, may play crucial roles in regulation of aqueous outflow resistance.Gene expression of the PG core protein was screened in human and bovine cultured TM cells by reverse transcription -initiated polymerase chain reaction (RT-PCR) and the RT-PCR experiments showed that cDNA fragments of the three PGs (decorin, lumican and fibromodulin). Subsequently, the TM cells were cultured with TGF-beta2, and the changes of gene expressions of the PGs were investigated. As a result, the expression of three PGs (decorin, lumican and fibromodulin) were up-regulated by TGF-beta2 stimulation.In addition, we assessed TGF-beta2 in aqueous humor which were collected from variable glaucomatous patients and non-glaucomatous (cataractous) patients with a specific-capture ELISA.Our study revealed that increased levels of TGF-beta2 in aqueous humor was found only in eyes with POAG,but not with EXS and PACG.These findings suggested that increased levels of TGF-beta2 may be different from other types of glaucoma.Furthrmore, we attempted to create a POAG model by means of TGF-beta2 gene transfer and resultant increase of proteolglycan production in TM cells, and in autocrine and/or paracrine manners of production. We have succeeded to efficiently introduce genes to primate and human TM cells by the HVJ liposome method. This results showed the potential of this method for a somatic gene therapy of the trabecular meshwork to treat glaucoma.These result suggested the potential role of increased levels of TGF-beta2 in aqueous humor and resultant increase of proteolglycan production in the pathogenesis of primary open angle glaucoma, and the gene transfer methods may be useful to treat glaucoma.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
K.Okazaki, H.Tanihara, M.Hangai, M.Inatani, M.Honjo, Y.Kaneda, B.Y.J.T.Yue, Y.Honda: "Facilitated introduction of DNA and oligonucleotides into primate trabecular meshwork cells by HVJ liposome methods." Invest Ophthalmil Vis Sci.(in press).
K.Okazaki、H.Tanihara、M.Hangai、M.Inatani、M.Honjo、Y.Kaneda、B.Y.J.T.Yue、Y.Honda:“通过 HVJ 脂质体方法促进将 DNA 和寡核苷酸引入灵长类小梁网细胞。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Muto T他: "Transforiming growth factor β2 up-regulated expression of proteoglycan decorin in trabecular meshwork cells." Invest Cphthalmol Vis.Sci. (印刷中). (1998)
Muto T 等人:“转化生长因子 β2 上调小梁网细胞中蛋白多糖核心蛋白的表达。”Invest Cphamol Vis.Sci(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanihara,et al.: "Prolonged impairment of peripheral corneal epithelial barrier function afper Successful frabeculectomy" American Journal of Ophthalmology. (印刷中). (1997)
Tanihara 等人:“成功的小梁切除术后周围角膜上皮屏障功能的长期损害”美国眼科杂志(1997 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Study on development of new therapeutic methods based on plasticity of trabecular meshwork cells
    • 批准号:
      17K19729
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.08万
    • 财政年份:
      2017
    • 负责人:
      TANIHARA Hidenobu
    • 依托单位:
    Investigation of glaucoma pathology focusing on epigenome and fibrocyte in aqueous humor dynamics and wound healing
    • 批准号:
      17H04351
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.9万
    • 财政年份:
      2017
    • 负责人:
      TANIHARA Hidenobu
    • 依托单位:
    4-dimention live imaging of inflamatory cells in conjunctiva after glaucoma surgery
    • 批准号:
      25670735
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      TANIHARA Hidenobu
    • 依托单位:
    Establishment of therapeutic assessment in glaucoma neuroprotection using live-imaging of axonal transport in optic nerve
    • 批准号:
      23659814
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      TANIHARA Hidenobu
    • 依托单位:
    国内基金
    海外基金
    探讨青光眼小梁滤过泡原位重建术及其诱导Decorin/TGF-β影响青光眼滤过通道瘢痕再形成的机制
    • 批准号:
      2024JJ7015
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
    • 依托单位:
    香烟烟雾通过Decorin-PAI-1-p53/p16调控肺泡成纤维细胞衰老在肺气肿的作用及干预研究
    • 批准号:
      82300047
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      胡蔚萍
    • 依托单位:
    Decorin通过负调控c-Met介导的PI3K/AKT/mTOR自噬通路影响瘢痕疙瘩发生发展的机制研究